Equatorial Guinea vs Panama: The number of people with susceptibility test result for rifampicin
Equatorial Guinea
492
in 2021
Panama
497
in 2021
Equatorial Guinea rank
80th
Panama rank
79th
The number of people with susceptibility test result for rifampicin over time
- Equatorial Guinea
- Panama
How they compare
Panama currently reports 497 against 492 in Equatorial Guinea, a difference of 5.
Across all 5 years both countries report, Panama has been ahead every year.
Equatorial Guinea ranks 80th and Panama ranks 79th of 155 countries.
Panama has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Equatorial Guinea | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 31.33 | 477 | 445.67 | Panama |
| 2020s | 371 | 452.5 | 81.5 | Panama |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Equatorial Guinea or Panama?
- Panama, at 497 against 492 in Equatorial Guinea as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Equatorial Guinea and Panama?
- 5, with Panama ahead.
- How many years of comparable data are there for Equatorial Guinea and Panama?
- 5 years are reported by both, from 2017 to 2021.
- How do Equatorial Guinea and Panama rank globally for the number of people with susceptibility test result for rifampicin?
- Equatorial Guinea ranks 80th and Panama ranks 79th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.